We want to revamp cardiac monitoring
Around 33% of cases of atrial fibrillation are asymptomatic, which makes it increasingly necessary to have an easy and effective way of diagnosing these patients.
Wearable solution that brings practicality and quality to exams
Long-term monitoring
Increases the diagnostic rate of clinically significant arrhythmias by up to 2x compared to 24-hour tests3
Instant capture
The patient's app captures heart signals in real time via Bluetooth.
AI analysis
It identifies rhythm abnormalities that are invisible to the human eye, such as Atrial Fibrillation.
Get a solution tailored to your needs.
The right solution for any type of health care center
Get a solution tailored to your needs.
Artificial Intelligence to improve diagnostic efficiency
Get a solution tailored to your needs.
It helps analyze and group signals, detecting patterns and anomalies in ECG data.
It allows large amounts of data to be analyzed quickly and patterns and trends indicative of arrhythmias to be identified.
With 3 derivations, it captures three times more data than competitors who use a single derivation.
Hospital
"Inpatients find the device more practical and it has made life much easier for the staff."
Hospital
"For those looking for a way to simplify the entire Holter diagnostic process. State-of-the-art technology, accurate diagnosis and super comfortable for the patient."
Doctor's Office
Doctor's Office
"The examination of more than 48 hours allows me a more in-depth diagnosis, which has already allowed me to identify abnormalities that led the patient to a timely procedure."
Medical
Medical
"An innovative solution that changes the way electrocardiographic exams are carried out, in a precise, efficient and comfortable way for the patient."
Diagnostic Center
"This is a modern information transmission system, which avoids signal problems and interference; from a medical point of view, it expands the possibilities for diagnosis, allowing an efficient, accurate and faster report."
Medical
"An advanced continuous electrocardiographic monitoring system that allows the recording of cardiac electrical activity in real time, ideal for identifying causes of syncope. This really is a breakthrough in cardiology."
Clinic
"Today we have the most modern and comfortable holter on the market. In 3 months of operation, we've increased our examination capacity by 40% with a 20% reduction in installation time."
QuoreOne is much more than a device, we bring you a totally innovative experience in use and acquisition
With no initial investment, payment per test performed and device subscription, you have access to a digital solution with qualitative and quantitative gains.
Digital technology
No cables or batteries;
Online exam streaming;
Prolonged monitoring of up to 7 days;
Artificial intelligence analysis.
Purchase on demand
Choose subscription by number of devices;
Choose the production plan for the exam;
You receive devices + charger at no extra cost;
You pay per test performed.
Business consulting
Customer understanding meeting;
Proposal customized to the needs presented;
Training in the installation and use of the cloud platform;
Support with educational material.
Analog technology
With cables or batteries;
Offline exam streaming;
Monitoring for up to 3 days;
Web platform analysis.
Acquisition by purchase
Buy the device and platform license;
Decapitalization;
You receive the device free of charge;
Maintenance costs (cables, batteries, belts, calibration).
Why buy when you can subscribe and pay per use?
You don't have to spend a lot of money to have short and long-term cardiac monitoring technology in your healthcare facility.
Monthly subscription
by device
It brings more practicality and availability, without worrying about maintaining cables, batteries and SD cards. You pay the subscription and get full support.
Implementing the technology
Upgrading technology
Replacement devices
Secure data storage
Technical support
Installation training
Platform training
Get a solution adapted to your needs
Choose the plan that best suits your needs
Customize our service to the dynamics of your health establishment, paying only for the tests you perform.
STANDARD
Device and Docking Station on loan
Unlimited Requestor app
Unlimited Patient app
Online streaming
Unlimited data platform access with editing
Review, classification and selection of rhythms by Artificial Intelligence
Rhythm interpretation
Final review carried out, generating pre-report
PREMIUM
Device and Docking Station on loan
Unlimited Requestor app
Unlimited Patient app
Online streaming
Unlimited data platform access with editing
Review, classification and selection of rhythms by Artificial Intelligence
Rhythm interpretation
Report reviewed and signed by physician Quoretech arrhythmologist
References on this page
2 - J.L. CLUA-ESPUNY ET AL. PREVALENCE OF UNDIAGNOSED ATRIAL FIBRILLATION AND OF THAT NOT BEING TREATED WITH ANTICOAGULANT DRUGS: THE AFABE STUDY , REV ESP CARDIOL. 2013;66(7):545-552
3 - Parikh P., et al, Diagnostic Yield of 24-hour Holter vs 7-day and 14-day epatch extended wear Holter, J Am Coll Cardiol. 2023 Mar, 81 (8_Supplement) 149
6 - SBC, II Brazilian Guidelines on Atrial Fibrillation, Volume 106, No. 4, Suppl. 2, April 2016
7 - SOBRAC, CAMPANHA CORAÇÃO NA BATIDA CERTA: BRASIL EM AÇÃO PELA PREVENÇÃO E TRATAMENTO DAS ARRRITMIAS CARDÍACAS E MORTESÚBIA, [https://sobrac.org/home/campanha-coracao-na-batida-certa-brasil-em-acao-pela-prevencao-e-tratamento-das-arritmias-cardiacas-emorte-subia/]
8 - ANS [https://www.gov.br/ans/pt-br/acesso-a-informacao/perfil-do-setor/dados-e-indicadores-do-setor]
9 - SUS [http://tabnet.datasus.gov.br/cgi/deftohtm.exe?sia/cnv/qauf.def]
10 - Kornej J., ET AL, Epidemiology of Atrial Fibrilation in the 21st Century - Novel Methods and New Insights, Circulation Research. 2020; 127;4-20. DOI: 10.1161/Circresaha. 120.31634